Previous Close | 0.0595 |
Open | 0.0595 |
Bid | 0.0551 x 0 |
Ask | 0.0630 x 0 |
Day's Range | 0.0595 - 0.0595 |
52 Week Range | 0.0510 - 0.1050 |
Volume | |
Avg. Volume | 45,643 |
Market Cap | 8.713M |
Beta (5Y Monthly) | N/A |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.0400 |
Earnings Date | Nov 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
Willow Biosciences Inc. ("Willow" or the "Company") (TSX: WLLW) (OTCQB: CANSF), a leading biotechnology company focused on revolutionizing industrial manufacturing of pure, consistent, and sustainable ingredients, announces its intention to complete a non-brokered private placement offering (the "Offering") on a best efforts basis for a minimum of 10,000,000 units and a maximum of up to 25,016,762 units of the Company (the "Units") at an issue price of C$0.08 per Unit for minimum gross proceeds
Willow Biosciences ( TSE:WLLW ) Third Quarter 2024 Results Key Financial Results Revenue: CA$1.70m (up 153% from 3Q...